Dr. Young is the Mid-Atlantic Medical Science Liaison for CSL Seqirus. He completed his Ph.D. in Biochemistry and Molecular Biology at the Medical University of South Carolina (MUSC), with a focus on drug design against antimicrobial resistant bacteria. He then matriculated to Emory University for his Post-Doctoral research where he was a Fellowships in Research and Science Teaching Scholar. His research focused on drug and vaccine design for Ebola virus. At CSL Seqirus we have a global focus on influenza, we work tirelessly on cutting-edge research, transformative technologies, and the latest methods of production and distribution.